Fabien Julémont

418 citations
14 papers · 370 indexed · h-index 11
Topics
Inflammatory mediators and NSAID effects (14 papers)Synthesis and biological activity (8 papers)Estrogen and related hormone effects (5 papers)
Partner nations
BelgiumFrance

In The Last Decade

Fabien Julémont

14 papers receiving 354 citations

Peers

Fabien Julémont
Comparison fields: 5 of 66
  • Organic Chemistry 193
  • Pharmacology 186
  • Molecular Biology 77
  • Genetics 43
  • Biochemistry 40
Replace H. SUGIHARA with:
H. SUGIHARA Japan
Clint D. W. Brooks United States
Nicolas Lebègue France
Carl Berthelette Canada
Charles Q. Meng Canada
Paola Anzellotti Italy
James L. Stanton Switzerland
Conrad Santini United States
Theodros Asberom United States
Candido Gude United States
Fabien Julémont relative to H. SUGIHARA Japan H. SUGIHARA's profile →
Citations per field
00.5×6.1×
H. SUGIHARA · 1×
Citations per year

Countries citing papers authored by Fabien Julémont

Since Specialization
Citations

This map shows the geographic impact of Fabien Julémont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Julémont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Julémont more than expected).

Fields of papers citing papers by Fabien Julémont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Julémont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Julémont. The network helps show where Fabien Julémont may publish in the future.

Co-authorship network of co-authors of Fabien Julémont

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Julémont. A scholar is included among the top collaborators of Fabien Julémont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Julémont. Fabien Julémont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 31
2 10
3 24
4 16
5 31
6 40
7 17
8 36
9 13
10 3
11 32
12 102
13 12
14 3

About Fabien Julémont

Fabien Julémont is a scholar working on Pharmacology, Organic Chemistry and Toxicology, having authored 14 papers that have together received 370 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (14 papers), Synthesis and biological activity (8 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Pharmacology (186 citations), Organic Chemistry (193 citations) and Toxicology (23 citations). Fabien Julémont has collaborated with scholars based in Belgium and France. Frequent co-authors include Xavier de Leval, Bernard Pirotte, Jean‐Michel Dogné, Catherine Michaux, J. Delarge, F. Durant, J. Damas, Caroline Charlier, Valérie Benoît and J. Delarge. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Current Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026